Our Faculty

Dr. Kulkarni is a multi-organ transplant surgeon and the Director of the Kidney Transplant Program at Yale University and Yale-New Haven Hospital. The clinical program has been one of the largest programs in New England since 2008, in terms of new patients listed, the number of living donor transplants, and the total number of kidney transplants performed. Clinical highlights of the program include an accelerated work-up and listing process (AJKD 2012;60(2):288, Healthgrades Award for overall program performance 2010, and implementation of a total laparoscopic kidney donation procedure. Watch a video with Dr. Sanjay Kulkarni >> Dr. Kulkarni is the principal investigator on numerous clinical research trials and projects. His research has focused on the use of anti-complement therapies to improve kidney graft survival and novel approaches to improving living donor outcomes through surgical innovations, including low-pressure laparoscopy. Ongoing research initiatives include the ethics and implementation of patient-centered care in the care of living donors through shared-decision making, identifying reasons why individuals opt out of donation, and fostering the development of local donor communities using a social capital framework. Appointed to the role of Physician Executive Director, Clinical Continuity & Integration for Yale-New Haven Hospital, Dr. Kulkarni aims to improve the patient experience by identifying areas of fractured care within the health system and implementing novel interventions to improve care coordination within the domain networks.

Ramesh Batra, MD, is the surgical director of liver transplant program at Yale Transplant Center. He is also a living donor liver surgeon for the transplant center besides being a multiorgan transplant surgeon for adult and pediatric patients. Alongside his transplant roles, he also performs complex hepatobiliary operations for liver tumors and biliary tract disorders in high risk patients. Dr. Batra's expertise is in living organ donation and also in transplanting extended spectrum aka “marginal” organs, both liver and kidneys for early transplant and reducing the time on organ transplant waiting list. With this ability, he continually seeks to find “opportunity” in organs declined by other transplant centers for his patients. Aside from maximizing utility and reducing organ discard, he is passionate about alleviating the ethical barriers in organ donation and transplantation. As a qualified and trained ethicist, he is nationally acclaimed in the field and constantly seeks to push the boundaries in organ transplantDr. Batra underwent the decade long robust training in United Kingdom expanding his transplant skills in adult and pediatric transplantation in London, and was subsequently admitted to the Membership and Fellowship of The Royal College of Surgeons of Edinburgh and Glasgow. He then completed the ASTS (American Society of Transplant Surgeons) abdominal transplant fellowship at the Mayo Clinic in liver, kidney and pancreas transplants along with pediatric liver transplants at Phoenix Children's hospital further strengthening the foundation of his surgical skills. At the Mayo Clinic, he was inspired by the institutional mission of building high transplant volume with excellent quality while considering patient at the centre of the delivered care; and he leads the program at Yale with that strategic vision.He is an active member of the American Society of Transplant Surgeons, American Society for Bioethics and Humanities, and also a Fellow of the American College of Surgeons. He currently serves on various national and international transplant and ethics committees along-with being on various editorial boards for medical and surgical journals to be at the forefront of transplant innovation.

Laurine M. Bow, Ph.D., HCLD (ABB) is board certified in the field of Diagnostic Immunology and earned her Ph.D. in Molecular Genetics and Cell Biology from the University of Connecticut in Storrs, CT. Dr. Bow is on the Board of Directors of Life Choice Donor Services and the World Affairs Council.Dr. Bow’s research interests include clinical relevance of HLA antibodies in organ transplantation, transplant immunology, and vascular biology.

David C. Mulligan, MD, is an abdominal organ transplant surgeon performing both living and deceased donor liver, kidney, and pancreas transplants. He currently serves as Professor of Surgery, Transplantation and Immunology in the Department of Surgery at Yale School of Medicine/Yale New Haven Health System. His clinical and academic focus surrounds living donor liver transplantation, expanding donation, and working on ways to utilize ex-vivo organ perfusion systems to increase transplantation in the United States. Dr. Mulligan and his team are testing novel strategies in immunosuppression; improved biomechanical organ preservation methods to reduce ischemia/reperfusion injury and promote regeneration; and working in the field of 3D bioprinting to collaborate in finding ways to grow new organs from stem cell precursors. He has performed more than 250 living donor transplants and has authored more that 180 publications. He also has served on numerous editorial review boards and presented across the U.S. and internationally. Dr. Mulligan’s leadership in solid organ transplantation across national and international platforms has grown considerably and he now serves as Past President of the United Network of Organ Sharing (UNOS)/Organ Procurement Transplant Network (OPTN), Member at-large on the Governing Board of the American Association for the Study of Liver Diseases, Past Chair of the Advisory Council on Transplantation (ACOT) to the Secretary of HHS, special government employee for FDA Medical Device Advisory Committee and chair of the Business Practice Committee of the American Society of Transplant Surgeons. He also contributes to the oversight and recommendations regarding the impacts of COVID-19 on solid organ transplantation in the U.S. for both the AASLD and the ASTS. In these visionary roles, he has led major changes in organ allocation and distribution and will hopefully culminate in substantial increases in organ transplants. Passionate about patient-centered care and building more resilient teams, he makes time to share his enjoyment of spending time in nature, especially near the ocean, with his wife and three children.